Beam Therapeutics
BEAM
#4700
Rank
S$2.79 B
Marketcap
S$26.97
Share price
-8.28%
Change (1 day)
-5.69%
Change (1 year)

P/S ratio for Beam Therapeutics (BEAM)

P/S ratio as of November 2026 (TTM): 14.8

According to Beam Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.03. At the end of 2026 the company had a P/S ratio of 17.3.

P/S ratio history for Beam Therapeutics from 2020 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202617.3-12.44%
202519.7-43.15%
202434.7490.16%
20235.87-87.02%
202245.2-56.8%
2021105-99.95%
2020> 1000

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA